Game of thrones: immunotherapy versus molecular targeted therapy in renal cell cancer scenarios.
Bulent CetinAlim KosarPublished in: International urology and nephrology (2019)
In renal cell carcinoma, rapid and successful drug development has resulted in multiple treatment options, requiring careful decision making for individual patients and have emphasized how newly developed therapies work.
Keyphrases
- end stage renal disease
- renal cell carcinoma
- decision making
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- papillary thyroid
- prognostic factors
- single cell
- cell therapy
- squamous cell
- patient reported outcomes
- mesenchymal stem cells
- lymph node metastasis
- loop mediated isothermal amplification